A detailed history of Orbimed Advisors LLC transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 6,059,528 shares of SCPH stock, worth $21 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
6,059,528
Previous 5,559,528 8.99%
Holding current value
$21 Million
Previous $24.2 Million 14.26%
% of portfolio
0.65%
Previous 0.58%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.12 - $5.51 $2.06 Million - $2.76 Million
500,000 Added 8.99%
6,059,528 $27.6 Million
Q4 2022

Feb 14, 2023

BUY
$4.02 - $7.53 $3.06 Million - $5.74 Million
762,380 Added 15.89%
5,559,528 $39.9 Million
Q2 2020

Aug 14, 2020

BUY
$7.01 - $10.96 $9.72 Million - $15.2 Million
1,387,283 Added 40.68%
4,797,148 $35.3 Million
Q4 2017

Feb 14, 2018

BUY
$11.8 - $17.31 $40.2 Million - $59 Million
3,409,865
3,409,865 $41.2 Million

Others Institutions Holding SCPH

About scPharmaceuticals Inc.


  • Ticker SCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,402,100
  • Market Cap $94.8M
  • Description
  • scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...
More about SCPH
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.